FDA Approved: LAMIVUDINE AND ZIDOVUDINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA has approved a supplemental Abbreviated New Drug Application for Lamivudine and Zidovudine from Aurobindo Pharma Limited, enabling the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lamivudine and Zidovudine (Lamivudine and Zidovudine)

Snippet

SUPPL AP for LAMIVUDINE AND ZIDOVUDINE (LAMIVUDINE AND ZIDOVUDINE)